Using Conditional Random Forest and Feature Ranking Algorithms to Determine the Relative Importance of the Nicotine Metabolite Ratio (NMR) and Demographic and Behavioral Factors on Nicotine Dependence Severity
Highlights
- Nicotine addiction is a major cause of premature mortality worldwide.
- Understanding the genetic and environmental risk factors is an important goal for nicotine pharmacotherapy. Machine learning is a technique often used to determine their relative importance.
- The nicotine metabolite ratio (NMR) has been a target for developing personalized therapy.
- There are many other nongenetic factors that have similar or more predictive determinants of addiction.
- Random forest is a useful technique to understand the multidimensional nature of nicotine dependence. Conditional random forest is a derivative technique adequately structured to account for datasets with variably scaled data.
- Personalized therapy based on the NMR should consider other dependence factors.
Abstract
1. Introduction
2. Materials and Methods
2.1. Data Collection and Study Design
2.2. Study Procedures
2.3. Outcome Measures
2.3.1. Nicotine Dependence
2.3.2. Perceived Stress
2.3.3. Psychological Distress
2.3.4. Morning Cravings or Urges to Smoke
2.3.5. Other Personal or Sociodemographic Factors
2.4. Biomarkers
Nicotine Metabolites
2.5. Analysis
2.5.1. Data Preparation
2.5.2. Statistical Analysis
Univariate and Bivariate Analysis
Conditional Random Forest Analysis
Parametric Regression Analysis
3. Results
3.1. Dependence Measures—Bivariate Analysis
3.1.1. FTND
3.1.2. HONC
3.1.3. HSI
3.2. Multivariate Models—Adjusted Associations and Variable Importance
3.2.1. Conditional Random Forest Models
3.2.2. Parametric Models
3.2.3. Statistical Interactions
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations, Measures, and Variable Acronyms
| Statistical Models and Analytical Methods | |
| BLR | Binary Logistic Regression |
| MLR | Multiple Linear Regression |
| RF-ML | Random Forest Machine Learning |
| Dependence Measures and Scale Instruments | |
| FTND | Fagerström Test for Nicotine Dependence |
| HONC | Hooked on Nicotine Checklist |
| HSI | Heaviness of Smoking Index |
| Biological Biomarkers and Variables | |
| 3HC | -3′-hydroxycotinine |
| 3HC-Gluc | -3′-hydroxycotinine glucuronide |
| COT | Cotinine |
| COT-Gluc | Cotinine glucuronide |
| log(NMR) | Log-transformed Nicotine Metabolite Ratio |
| NMR | Nicotine Metabolite Ratio (ratio of total 3HC to total cotinine) |
| TNE | Total Nicotine Equivalents |
| Descriptive and Statistical Terms | |
| CPD | Cigarettes Per Day |
| n | Sample Size/Count |
| p | -value (Statistical Significance) |
| SD | Standard Deviation |
| SC | Standardized Coefficient |
| Cforest | Conditional Random Forest |
| Variable Terms | |
| HH | Household |
| CPD | Cigarettes Per Day |
| SES | Socioeconomic Status |
Appendix A
| Variable Type | Variable | Class | Complete Case | Imputed Data |
|---|---|---|---|---|
| n (%) or Mean (SD) | n (%) or Mean (SD) | |||
| Demographic and SES Covariates | Age | - | 37.8 (11.6) | 38.1 (11.4) |
| Sex | F | 169 (56.5) | 184 (57.9) | |
| M | 130 (43.5) | 134 (42.1) | ||
| Race | White | 259 (86.6) | 275 (86.5) | |
| African American (AA) | 27 (9.0) | 29 (9.1) | ||
| Other | 13 (4.3) | 14 (4.4) | ||
| Height | - | 66.8 (4.0) | 66.8 (4.0) | |
| Weight | - | 180.7 (48.8) | 180.7 (48.8) | |
| BMI | - | 28.4 (7.0) | 28.4 (6.9) | |
| Household Income | - | 56.7k (38.4k) | 56.0k (37.2k) | |
| Number in HH | - | 3.2 (1.5) | 3.2 (1.5) | |
| Education Level | LT College Grad | 224 (74.9) | 237 (74.5) | |
| College Grad or Higher | 75 (25.1) | 81(25.5) | ||
| Job Type | White | 87 (29.2) | 90 (28.3) | |
| Blue | 83 (27.9) | 87 (27.4) | ||
| Pink | 82 (27.5) | 86 (27.0) | ||
| Unemployed (all reasons) | 46 (15.4) | 55 (17.3) | ||
| Health Insurance | N | 80 (26.8) | 85 (26.7) | |
| Y | 218 (73.2) | 233 (73.3) | ||
| Behavioral | Perceived Stress | - | 16.9 (4.7) | 16.9 (4.7) |
| Serious Stress | - | 6.0 (4.4) | 6.0 (4.4) | |
| Depression | - | 0.5 (0.8) | 0.5 (0.8) | |
| Smoking Measures | Cotinine | - | 303.8 (222.9) | 303.8 (222.9) |
| 3′-hydroxycotinine (3HC) | - | 164.2 (694.0) | 164.2 (694.0) | |
| NMR | - | 0.53 (1.4) | 0.53 (1.4) | |
| Log(NMR) | - | −1.0 (0.7) | −1.0 (0.7) | |
| Awaken to Smoke | N | 215 (72.2) | 228 (71.7) | |
| Y | 83 (27.8) | 90 (28.3) | ||
| Age Smoke Regularly | - | 16.9 (4.7) | 16.9 (4.7) | |
| Cigarettes per day | - | 16.3 (8.0) | 16.3 (8.0) | |
| Outcome(s) Dependence Measures | Fagerstrom Test (FTND) | - | 4.3 (2.3) | 4.3 (2.3) |
| HONC Score | - | 7.3 (2.1) | 7.3 (2.1) | |
| HSI | - | 2.9 (1.6) | 2.9 (1.6) |
| Model | Variable | Class | FTND | Variable | Class | HONC | Variable | Class | HSI | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SC | p-Value | Rank (SC) | SC | p-Value | Rank (SC) | SC | p-Value | Rank (SC) | |||||||
| MLR | NMR*Ed level | College Grad (AS or Higher) | −0.18 | 0.0467 | 3 | Wake Urge*Log(NMR) | −0.35 | 0.0157 | 2 | - | - | - | - | - | |
| BLR | NMR*Ed level | College Grad (AS or Higher) | −0.35 | 0.0510 | 2 | Race*Log(NMR) | −0.37 | 0.0512 | 2 | - | - | - | - | - | |


References
- Kyerematen, G.A.; Vesell, E.S. Metabolism of nicotine. Drug Metab. Rev. 1991, 23, 3–41. [Google Scholar] [CrossRef] [Scilit]
- Benowitz, N.L.; Dains, K.M.; Dempsey, D.; Herrera, B.; Yu, L.; Jacob, P., III. Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure. Nicotine Tob. Res. 2009, 11, 954–960. [Google Scholar] [CrossRef] [Scilit]
- Tutka, P.; Mosiewicz, J.; Wielosz, M. Pharmacokinetics and metabolism of nicotine. Pharmacol. Rep. 2005, 57, 143–153. [Google Scholar] [CrossRef] [Scilit]
- Messina, E.; Tyndale, R.; Sellers, E. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J. Pharmacol. Exp. Ther. 1997, 282, 1608–1614. [Google Scholar] [CrossRef] [Scilit]
- Nakajima, M.; Kwon, J.T.; Tanaka, N.; Zenta, T.; Yamamoto, Y.; Yamamoto, H.; Yamazaki, H.; Yamamoto, T.; Kuroiwa, Y.; Yokoi, T. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin. Pharmacol. Ther. 2001, 69, 72–78. [Google Scholar] [CrossRef] [Scilit]
- Moyer, T.P.; Charlson, J.R.; Enger, R.J.; Dale, L.C.; Ebbert, J.O.; Schroeder, D.R.; Hurt, R.D. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin. Chem. 2002, 48, 1460–1471. [Google Scholar] [CrossRef] [Scilit]
- St. Helen, G.; Novalen, M.; Heitjan, D.F.; Dempsey, D.; Jacob, P., III; Aziziyeh, A.; Wing, V.C.; George, T.P.; Tyndale, R.F.; Benowitz, N.L. Reproducibility of the nicotine metabolite ratio in cigarette smokers. Cancer Epidemiol. Biomark. Prev. 2012, 21, 1105–1114. [Google Scholar] [CrossRef] [Scilit]
- Benowitz, N.L.; St. Helen, G.; Nardone, N.; Cox, L.S.; Jacob, P., III. Urine metabolites for estimating daily intake of nicotine from cigarette smoking. Nicotine Tob. Res. 2020, 22, 288–292. [Google Scholar] [CrossRef] [Scilit]
- Chenoweth, M.J.; Novalen, M.; Hawk, L.W., Jr.; Schnoll, R.A.; George, T.P.; Cinciripini, P.M.; Lerman, C.; Tyndale, R.F. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Cancer Epidemiol. Biomark. Prev. 2014, 23, 1773–1782. [Google Scholar] [CrossRef] [Scilit]
- Johnstone, E.; Benowitz, N.; Cargill, A.; Jacob, R.; Hinks, L.; Day, I.; Murphy, M.; Walton, R. Determinants of the rate of nicotine metabolism and effects on smoking behavior. Clin. Pharmacol. Ther. 2006, 80, 319–330. [Google Scholar] [CrossRef] [Scilit]
- Jain, R.B. Nicotine metabolite ratios in serum and urine among US adults: Variations across smoking status, gender and race/ethnicity. Biomarkers 2020, 25, 27–33. [Google Scholar] [CrossRef] [Scilit]
- Kandel, D.B.; Hu, M.-C.; Schaffran, C.; Udry, J.R.; Benowitz, N.L. Urine nicotine metabolites and smoking behavior in a multiracial/multiethnic national sample of young adults. Am. J. Epidemiol. 2007, 165, 901–910. [Google Scholar] [CrossRef] [Scilit]
- Richards, J.M.; Stipelman, B.A.; Bornovalova, M.A.; Daughters, S.B.; Sinha, R.; Lejuez, C. Biological mechanisms underlying the relationship between stress and smoking: State of the science and directions for future work. Biol. Psychol. 2011, 88, 1–12. [Google Scholar] [CrossRef] [Scilit]
- Allenby, C. The Effect of Abstinence from Smoking on Stress Reactivity. Ph.D. Thesis, University of Pennsylvania, Philadelphia, PA, USA, 2019. [Google Scholar]
- West, O.; Hajek, P.; McRobbie, H. Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence. Psychopharmacology 2011, 218, 313–322. [Google Scholar] [CrossRef] [Scilit]
- Carroll, D.M.; Murphy, S.E.; Benowitz, N.L.; Strasser, A.A.; Kotlyar, M.; Hecht, S.S.; Carmella, S.G.; McClernon, F.J.; Pacek, L.R.; Dermody, S.S.; et al. Relationships between the nicotine metabolite ratio and a panel of exposure and effect biomarkers: Findings from two studies of US commercial cigarette smokers. Cancer Epidemiol. Biomark. Prev. 2020, 29, 871–879. [Google Scholar] [CrossRef] [Scilit]
- Strasser, A.A.; Benowitz, N.L.; Pinto, A.G.; Tang, K.Z.; Hecht, S.S.; Carmella, S.G.; Tyndale, R.F.; Lerman, C.E. Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer Epidemiol. Biomark. Prev. 2011, 20, 234–238. [Google Scholar] [CrossRef] [Scilit]
- Chen, A.; Krebs, N.M.; Zhu, J.; Muscat, J.E. Nicotine metabolite ratio predicts smoking topography: The Pennsylvania Adult Smoking Study. Drug Alcohol Depend. 2018, 190, 89–93. [Google Scholar] [CrossRef] [Scilit]
- Benowitz, N.L.; Pomerleau, O.F.; Pomerleau, C.S.; Jacob, P., III. Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine Tob. Res. 2003, 5, 621–624. [Google Scholar] [CrossRef] [Scilit]
- Vaz, L.R.; Coleman, T.; Cooper, S.; Aveyard, P.; Leonardi-Bee, J.; SNAP Trial Team. The nicotine metabolite ratio in pregnancy measured by trans-3′-hydroxycotinine to cotinine ratio: Characteristics and relationship with smoking cessation. Nicotine Tob. Res. 2015, 17, 1318–1323. [Google Scholar] [CrossRef] [Scilit]
- Schoedel, K.A.; Hoffmann, E.B.; Rao, Y.; Sellers, E.M.; Tyndale, R.F. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics 2004, 14, 615–626. [Google Scholar] [CrossRef] [Scilit]
- Schnoll, R.A.; George, T.P.; Hawk, L.; Cinciripini, P.; Wileyto, P.; Tyndale, R.F. The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race. Psychopharmacology 2014, 231, 2515–2523. [Google Scholar] [CrossRef] [Scilit]
- Keke, C.; Wilson, Z.; Lebina, L.; Motlhaoleng, K.; Abrams, D.; Variava, E.; Gupte, N.; Niaura, R.; Martinson, N.; Golub, J.E.; et al. A Cross-Sectional Analysis of the Nicotine Metabolite Ratio and Its Association with Sociodemographic and Smoking Characteristics among People with HIV Who Smoke in South Africa. Int. J. Environ. Res. Public Health 2023, 20, 5090. [Google Scholar] [CrossRef] [Scilit]
- Malaiyandi, V.; Sellers, E.M.; Tyndale, R.F. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin. Pharmacol. Ther. 2005, 77, 145–158. [Google Scholar] [CrossRef] [Scilit]
- Verplaetse, T.L.; Peltier, M.R.; Roberts, W.; Moore, K.E.; Pittman, B.P.; McKee, S.A. Associations between nicotine metabolite ratio and gender with transitions in cigarette smoking status and e-cigarette use: Findings across waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) study. Nicotine Tob. Res. 2020, 22, 1316–1321. [Google Scholar] [CrossRef] [Scilit]
- Chenoweth, M.J.; Schnoll, R.A.; Novalen, M.; Hawk, L.W.; George, T.P.; Cinciripini, P.M.; Lerman, C.; Tyndale, R.F. The nicotine metabolite ratio is associated with early smoking abstinence even after controlling for factors that influence the nicotine metabolite ratio. Nicotine Tob. Res. 2016, 18, 491–495. [Google Scholar] [CrossRef] [Scilit]
- Fix, B.V.; O’Connor, R.J.; Benowitz, N.; Heckman, B.W.; Cummings, K.M.; Fong, G.T.; Thrasher, J.F. Nicotine metabolite ratio (NMR) prospectively predicts smoking relapse: Longitudinal findings from ITC surveys in five countries. Nicotine Tob. Res. 2017, 19, 1040–1047. [Google Scholar] [CrossRef] [Scilit]
- Ho, M.K.; Mwenifumbo, J.C.; Al Koudsi, N.; Okuyemi, K.S.; Ahluwalia, J.S.; Benowitz, N.L.; Tyndale, R.F. Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers. Clin. Pharmacol. Ther. 2009, 85, 635–643. [Google Scholar] [CrossRef] [Scilit]
- Shahab, L.; Bauld, L.; McNeill, A.; Tyndale, R.F. Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real-world settings? A prospective study. Addiction 2019, 114, 304–314. [Google Scholar] [CrossRef] [Scilit]
- Olawade, D.B.; Aienobe-Asekharen, C.A. Artificial intelligence in tobacco control: A systematic scoping review of applications, challenges, and ethical implications. Int. J. Med. Inform. 2025, 202, 105987. [Google Scholar] [CrossRef] [Scilit]
- Bartoszuk, B.M.; Gagolewski, M. Variable importance plots: An introduction to the vip package. R J. 2020, 12, 343–366. [Google Scholar] [CrossRef] [Scilit]
- Strobl, C.; Boulesteix, A.-L.; Zeileis, A.; Hothorn, T. Bias in random forest variable importance measures: Illustrations, sources and a solution. BMC Bioinform. 2007, 8, 25. [Google Scholar] [CrossRef] [Scilit]
- Strobl, C.; Boulesteix, A.-L.; Kneib, T.; Augustin, T.; Zeileis, A. Conditional variable importance for random forests. BMC Bioinform. 2008, 9, 307. [Google Scholar] [CrossRef] [Scilit]
- Levshina, N. Conditional inference trees and random forests. In A Practical Handbook of Corpus Linguistics; Springer: Berlin/Heidelberg, Germany, 2021; pp. 611–643. [Google Scholar]
- Hothorn, T.; Zeileis, A. partykit: A modular toolkit for recursive partytioning in R. J. Mach. Learn. Res. 2015, 16, 3905–3909. [Google Scholar]
- Hothorn, T.; Hornik, K.; Zeileis, A. Unbiased recursive partitioning: A conditional inference framework. J. Comput. Graph. Stat. 2006, 15, 651–674. [Google Scholar] [CrossRef] [Scilit]
- Krebs, N.M.; Chen, A.; Zhu, J.; Sun, D.; Liao, J.; Stennett, A.L.; Muscat, J.E. Comparison of puff volume with cigarettes per day in predicting nicotine uptake among daily smokers. Am. J. Epidemiol. 2016, 184, 48–57. [Google Scholar] [CrossRef] [Scilit]
- Hiscock, R.; Bauld, L.; Amos, A.; Fidler, J.A.; Munafò, M. Socioeconomic status and smoking: A review. Ann. N. Y. Acad. Sci. 2012, 1248, 107–123. [Google Scholar] [CrossRef] [Scilit]
- Heatherton, T.F.; Kozlowski, L.T.; Frecker, R.C.; Fagerstrom, K.O. The Fagerström test for nicotine dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addctn. 1991, 86, 1119–1127. [Google Scholar] [CrossRef] [Scilit]
- Borland, R.; Yong, H.-H.; O’connor, R.; Hyland, A.; Thompson, M. The reliability and predictive validity of the Heaviness of Smoking Index and its two components: Findings from the International Tobacco Control Four Country study. Nicotine Tob. Res. 2010, 12, S45–S50. [Google Scholar] [CrossRef] [Scilit]
- Heatherton, T.F.; Kozlowski, L.T.; Frecker, R.C.; Rickert, W.; Robinson, J. Measuring the heaviness of smoking: Using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br. J. Addctn. 1989, 84, 791–800. [Google Scholar] [CrossRef] [Scilit]
- Sujal, P.; Anand, P.; Abhishek, S. Heaviness of smoking index versus fagerstrom test for nicotine dependence among current smokers of Ahmedabad city, India. Addctn. Health 2021, 13, 29. [Google Scholar]
- Wellman, R.J.; DiFranza, J.R.; Savageau, J.A.; Godiwala, S.; Friedman, K.; Hazelton, J. Measuring adults’ loss of autonomy over nicotine use: The Hooked on Nicotine Checklist. Nicotine Tob. Res. 2005, 7, 157–161. [Google Scholar] [CrossRef] [Scilit]
- Kline, P. Handbook of Psychological Testing; Routledge: Abingdon, UK, 2013. [Google Scholar]
- Cohen, S.; Kamarck, T.; Mermelstein, R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 24, 385–396. [Google Scholar] [CrossRef] [Scilit]
- Lawless, M.H.; Harrison, K.A.; Grandits, G.A.; Eberly, L.E.; Allen, S.S. Perceived stress and smoking-related behaviors and symptomatology in male and female smokers. Addctv. Behav. 2015, 51, 80–83. [Google Scholar] [CrossRef] [Scilit]
- Kessler, R.C.; Andrews, G.; Colpe, L.J.; Hiripi, E.; Mroczek, D.K.; Normand, S.-L.; Walters, E.E.; Zaslavsky, A.M. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol. Med. 2002, 32, 959–976. [Google Scholar] [CrossRef] [Scilit]
- Kessler, R.C.; Green, J.G.; Gruber, M.J.; Sampson, N.A.; Bromet, E.; Cuitan, M.; Furukawa, T.A.; Gureje, O.; Hinkov, H.; Hu, C.Y.; et al. Screening for serious mental illness in the general population with the K6 screening scale: Results from the WHO World Mental Health (WMH) survey initiative. Int. J. Methods Psychiatr. Res. 2010, 19, 4–22. [Google Scholar] [CrossRef] [Scilit]
- Zvolensky, M.J.; Jardin, C.; Wall, M.M.; Gbedemah, M.; Hasin, D.; Shankman, S.A.; Gallagher, M.W.; Bakhshaie, J.; Goodwin, R.D. Psychological distress among smokers in the United States: 2008–2014. Nicotine Tob. Res. 2018, 20, 707–713. [Google Scholar] [CrossRef] [Scilit]
- Altun, Y. Relationship of nicotine dependence with depression, anxiety and psychological distress. Med. Sci. Int. Med. J. 2021, 10, 868–872. [Google Scholar] [CrossRef] [Scilit]
- Park, S.H.; Lee, L.; Shearston, J.A.; Weitzman, M. Patterns of electronic cigarette use and level of psychological distress. PLoS ONE 2017, 12, e0173625. [Google Scholar] [CrossRef] [Scilit]
- Leung, J.; Gartner, C.; Dobson, A.; Lucke, J.; Hall, W. Psychological distress is associated with tobacco smoking and quitting behaviour in the Australian population: Evidence from national cross-sectional surveys. Aust. N. Z. J. Psychiatry 2011, 45, 170–178. [Google Scholar] [CrossRef] [Scilit]
- Branstetter, S.A.; Krebs, N.M.; Chen, A.; Sun, D.; Zhu, J.; Muscat, J.E. Temporal Dynamics of Smoking Urges: Investigating Morning Cravings, Nicotine Dependence, and Smoking Behaviors. Subst. Use Misuse 2025, 60, 1490–1496. [Google Scholar] [CrossRef] [Scilit]
- U.S. Bureau of Labor Statistics SOPC. 2010 SOC User Guide in: Standard Occupational Classification Policy Committee. 2010. Available online: https://www.bls.gov/soc/ (accessed on 25 June 2026).
- Moeur, M.; Stage, A.R. Most similar neighbor: An improved sampling inference procedure for natural resource planning. For. Sci. 1995, 41, 337–359. [Google Scholar] [CrossRef] [Scilit]
- Crookston, N.L.; Finley, A.O. yaImpute: An R package for kNN imputation. J. Stat. Softw. 2008, 23, 1–16. [Google Scholar]
- Jadhav, A.; Pramod, D.; Ramanathan, K. Comparison of performance of data imputation methods for numeric dataset. Appl. Artif. Intell. 2019, 33, 913–933. [Google Scholar] [CrossRef] [Scilit]
- de Andrade Silva, J.; Hruschka, E.R. An experimental study on the use of nearest neighbor-based imputation algorithms for classification tasks. Data Knowl. Eng. 2013, 84, 47–58. [Google Scholar] [CrossRef] [Scilit]
- Choudhury, A.; Kosorok, M.R. Missing data imputation for classification problems. arXiv 2020, arXiv:2002.10709. [Google Scholar]
- Waljee, A.K.; Mukherjee, A.; Singal, A.G.; Zhang, Y.; Warren, J.; Balis, U.; Marrero, J.; Zhu, J.; Higgins, P.D. Comparison of imputation methods for missing laboratory data in medicine. BMJ Open 2013, 3, e002847. [Google Scholar] [CrossRef] [Scilit]
- Batista, G.E.; Monard, M.C. A study of K-nearest neighbour as an imputation method. His 2002, 87, 48. [Google Scholar]
- Mohammed, M.; Zulkafli, H.; Adam, M.; Ali, N.; Baba, I. Comparison of five imputation methods in handling missing data in a continuous frequency table. AIP Conf. Proc. 2021, 2355, 040006. [Google Scholar] [CrossRef] [Scilit]
- Tutz, G.; Ramzan, S. Improved methods for the imputation of missing data by nearest neighbor methods. Comput. Stat. Data Anal. 2015, 90, 84–99. [Google Scholar] [CrossRef] [Scilit]
- Breiman, L. Random forests. Mach. Learn. 2001, 45, 5–32. [Google Scholar] [CrossRef] [Scilit]
- Hastie, T.; Tibshirani, R.; Friedman, J. Random forests. In The Elements of Statistical Learning: Data Mining, Inference, and Prediction; Springer: New York, NY, USA, 2009; pp. 587–604. [Google Scholar]
- Biau, G. Analysis of a random forests model. J. Mach. Learn. Res. 2012, 13, 1063–1095. [Google Scholar]
- Liaw, A.; Wiener, M. Classification and regression by randomForest. R News 2002, 2, 18–22. [Google Scholar]
- Cutler, A.; Cutler, D.R.; Stevens, J.R. Random forests. In Ensemble Machine Learning: Methods and Applications; Springer: New York, NY, USA, 2012; pp. 157–175. [Google Scholar]
- Biau, G.; Scornet, E. A random forest guided tour. Test 2016, 25, 197–227. [Google Scholar] [CrossRef] [Scilit]
- Kleinbaum, D.G.; Dietz, K.; Gail, M.; Klein, M.; Klein, M. Logistic Regression; Springer: Berlin/Heidelberg, Germany, 2002. [Google Scholar]
- Ryo, M.; Rillig, M. Statistically reinforced machine learning for nonlinear patterns and variable interactions. Ecosphere 2017, 8, e01976. [Google Scholar] [CrossRef] [Scilit]
- Korte, K.J.; Capron, D.W.; Zvolensky, M.; Schmidt, N.B. The Fagerström test for nicotine dependence: Do revisions in the item scoring enhance the psychometric properties? Addctv. Behav. 2013, 38, 1757–1763. [Google Scholar] [CrossRef] [Scilit]
- Tanner, J.-A.; Zhu, A.Z.; Claw, K.G.; Prasad, B.; Korchina, V.; Hu, J.; Doddapaneni, H.; Muzny, D.M.; Schuetz, E.G.; Lerman, C.; et al. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. Pharmacogenetics Genom. 2018, 28, 7–16. [Google Scholar] [CrossRef] [Scilit]
- El-Boraie, A.; Tanner, J.A.; Zhu, A.Z.X.; Claw, K.G.; Prasad, B.; Schuetz, E.G.; Thummel, K.E.; Fukunaga, K.; Mushiroda, T.; Kubo, M.; et al. Functional characterization of novel rare CYP2A6 variants and potential implications for clinical outcomes. Clin. Transl. Sci. 2022, 15, 204–220. [Google Scholar] [CrossRef] [Scilit]
- Tanner, J.-A.; Tyndale, R.F. Variation in CYP2A6 Activity and Personalized Medicine. J. Pers. Med. 2017, 7, 18. [Google Scholar] [CrossRef] [Scilit]
- Siegel, S.D.; Lerman, C.; Flitter, A.; Schnoll, R.A. The use of the nicotine metabolite ratio as a biomarker to personalize smoking cessation treatment: Current evidence and future directions. Cancer Prev. Res. 2020, 13, 261–272. [Google Scholar] [CrossRef] [Scilit]



| Variable | Class/Statistic | Overall (n = 318) | Dependence Measures | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FTND | p-Value | HONC | p-Value | HSI | p-Value | ||||||
| Low to Mod (n = 167) | Mod to High (n = 151) | Low to Mod (n = 139) | Mod to High (n = 179) | Low to Mod (0–3) (n = 195) | Mod to High (4–6) (n = 123) | ||||||
| Age (yrs) | Mean (SD) | 38.1 (11.5) | 35.9 (10.8) | 40.5 (11.7) | 0.0003 | 38.0 (11.3) | 38.1 (11.6) | 0.9388 | 36.5 (11.6) | 40.6 (10.8) | 0.0020 |
| Median [Min, Max] | 38.0 [18.0, 60.0] | 34.0 [18.0, 60.0] | 41.0 [18.0, 60.0] | 37.0 [18.0,60.0] | 38.0 [18.0, 60.0] | 34.0 [18.0, 60.0] | 42.0 [18.0, 60.0] | ||||
| Sex | F | 184 (57.9%) | 101 (60.5%) | 83 (55.0%) | 0.3787 | 69 (49.6%) | 115 (64.2%) | 0.0124 | 115 (59.0%) | 69 (56.1%) | 0.6970 |
| M | 134 (42.1%) | 66 (39.5%) | 68 (45.0%) | 70 (50.4%) | 64 (35.8%) | 80 (41.0%) | 54 (43.9%) | ||||
| Race | White | 275 (86.5%) | 142 (85.0%) | 133 (88.1%) | 0.2760 | 115 (82.7%) | 160 (89.4%) | 0.0414 | 162 (83.1%) | 113 (91.9%) | 0.0419 |
| AA | 29 (9.1%) | 19 (11.4%) | 10 (6.6%) | 19 (13.7%) | 10 (5.6%) | 24 (12.3%) | 5 (4.1%) | ||||
| Other | 14 (4.4%) | 6 (3.6%) | 8 (5.3%) | 5 (3.6%) | 9 (5.0%) | 9 (4.6%) | 5 (4.1%) | ||||
| BMI (lbs./in2) | Mean (SD) | 28.4 (7.0) | 28.2 (6.4) | 28.6 (7.5) | 0.6056 | 28.4 (6.6) | 28.4 (7.2) | 0.9590 | 28.0 (6.7) | 29.0 (7.4) | 0.2486 |
| Median [Min, Max] | 26.7 [17.2, 56.5] | 26.9 [17.2, 45.3] | 26.6 [17.4, 56.5] | 27.3 [17.2, 56.5] | 26.5 [17.4, 53.2] | 26.5 [17.2, 56.5] | 27.0 [17.4, 53.2] | ||||
| Household Income (USD 1000) | Mean (SD) | 56.1 (37.2) | 60.5 (34.4) | 51.3 (39.6) | 0.0272 | 63.1 (36.5) | 50.7 (36.9) | 0.0032 | 59.4 (34.4) | 50.8 (40.8) | 0.0439 |
| Median [Min, Max] | 50.0 [0, 279.0] | 60.0 [0, 200.0] | 40.0 [2.0, 279.0] | 60.0 [3.0, 180.0] | 45.0 [0, 279.0] | 55.0 [0, 200.0] | 40.0 [2.0, 279.0] | ||||
| Number in Household | Mean (SD) | 3.2 (1.5) | 3.3 (1.4) | 3.1 (1.5) | 0.2482 | 3.3 (1.5) | 3.1 (1.4) | 0.2145 | 3.2 (1.5) | 3.1 (1.5) | 0.4300 |
| Median [Min, Max] | 3.0 [1.0, 8.0] | 3.0 [1.0, 8.0] | 3.0 [1.0, 8.0] | 3.0 [1.0, 8.0] | 3.0 [1.0, 7.0] | 3.0 [1.0, 8.0] | 3.0 [1.0, 7.0] | ||||
| Education Level | Less Than College | 237 (74.5%) | 110 (65.9%) | 127 (84.1%) | 0.0003 | 97 (69.8%) | 140 (78.2%) | 0.1138 | 131 (67.2%) | 106 (86.2%) | 0.0003 |
| College or Higher | 81 (25.5%) | 57 (34.1%) | 24 (15.9%) | 42 (30.2%) | 39 (21.8%) | 64 (32.8%) | 17 (13.8%) | ||||
| Job Type | White Collar | 90 (28.3%) | 37 (22.2%) | 53 (35.1%) | 0.0132 | 40 (28.8%) | 50 (27.9%) | 0.1055 | 47 (24.1%) | 43 (35.0%) | 0.0070 |
| Blue Collar | 87 (27.4%) | 51 (30.5%) | 36 (23.8%) | 41 (29.5%) | 46 (25.7%) | 60 (30.8%) | 27 (22.0%) | ||||
| Pink Collar | 86 (27.0%) | 54 (32.3%) | 32 (21.2%) | 42 (30.2%) | 44 (24.6%) | 61 (31.3%) | 25 (20.3%) | ||||
| Unemployed (all reasons) | 55 (17.3%) | 25 (15.0%) | 30 (19.9%) | 16 (11.5%) | 39 (21.8%) | 27 (13.8%) | 28 (22.8%) | ||||
| Insurance Status | No | 85 (26.7%) | 42 (25.1%) | 43 (28.5%) | 0.5874 | 38 (27.3%) | 47 (26.3%) | 0.9296 | 47 (24.1%) | 38 (30.9%) | 0.2291 |
| Yes | 233 (73.3%) | 125 (74.9%) | 108 (71.5%) | 101 (72.7%) | 132 (73.7%) | 148 (75.9%) | 85 (69.1%) | ||||
| Perceived Stress | Mean (SD) | 16.9 (7.3) | 15.9 (7.1) | 18.0 (7.4) | 0.0118 | 13.9 (6.7) | 19.2 (7.0) | <0.0001 | 15.9 (7.1) | 18.4 (7.5) | 0.0029 |
| Median [Min, Max] | 16.0 [1.0, 37.0] | 16.0 [1.0, 34.0] | 18.0 [1.0, 37.0] | 14.0 [1.0, 33.0] | 19.0 [1.0, 37.0] | 16.0 [1.0, 34.0] | 18.0 [1.0, 37.0] | ||||
| Serious Stress | Mean (SD) | 6.0 (4.4) | 5.4 (3.9) | 6.7 (4.7) | 0.0061 | 4.5 (3.8) | 7.2 (4.5) | <0.0001 | 5.5 (3.9) | 6.9 (4.9) | 0.0055 |
| Median [Min, Max] | 5.0 [0, 23.0] | 5.0 [0, 19.0] | 5.0 [0, 23.0] | 4.0 [0, 19.0] | 6.0 [0, 23.0] | 5.0 [0, 19.0] | 5.0 [0, 23.0] | ||||
| Depressed (2 wks. or more) | No | 178 (56.0%) | 109 (65.3%) | 69 (45.7%) | 0.0007 | 95 (68.3%) | 83 (46.4%) | 0.0001 | 122 (62.6%) | 56 (45.5%) | 0.0042 |
| Yes | 140 (44.0%) | 58 (34.7%) | 82 (54.3%) | 44 (31.7%) | 96 (53.6%) | 73 (37.4%) | 67 (54.5%) | ||||
| Salivary Cotinine (ng/mL) | Mean (SD) | 304 (223) | 257 (196) | 356 (240) | 0.0001 | 285 (184) | 318 (249) | 0.1894 | 259 (190) | 375 (252) | <0.0001 |
| Median [Min, Max] | 267 [3.2, 2530] | 220 [3.2, 1580] | 326 [7.3, 2530] | 253 [5.3, 1020] | 277 [3.2, 2530] | 221 [3.2, 1580] | 335 [91.9, 2530] | ||||
| Salivary 3HC (ng/mL) | Mean (SD) | 164 (694) | 100 (92.5) | 235 (999) | 0.0840 | 112 (99.2) | 205 (920) | 0.2350 | 102 (103) | 263 (1100) | 0.0438 |
| Median [Min, Max] | 98.8 [0.88, 12,300] | 73.1 [0.88, 621] | 121 [0.91, 12,300] | 87.8 [0.88, 537] | 106 [0.91, 12,300] | 73.8 [0.880, 787] | 133 [23.5, 12,300] | ||||
| Wake Urge | Mean (SD) | 5.84 (2.64) | 4.61 (2.23) | 7.20 (2.39) | <0.0001 | 4.90 (2.47) | 6.58 (2.54) | <0.0001 | 4.88 (2.33) | 7.37 (2.37) | <0.0001 |
| Median [Min, Max] | 6.00 [1.00, 10.0] | 5.00 [1.00, 10.0] | 7.50 [1.00, 10.0] | 5.00 [1.00, 10.0] | 7.00 [1.00, 10.0] | 5.00 [1.00, 10.0] | 7.50 [1.00, 10.0] | ||||
| Awaken to Smoke | No | 228 (71.7%) | 143 (85.6%) | 85 (56.3%) | <0.0001 | 115 (82.7%) | 113 (63.1%) | 0.0002 | 160 (82.1%) | 68 (55.3%) | <0.0001 |
| Yes | 90 (28.3%) | 24 (14.4%) | 66 (43.7%) | 24 (17.3%) | 66 (36.9%) | 35 (17.9%) | 55 (44.7%) | ||||
| Age Smoked Regularly (yrs) | Mean (SD) | 16.9 (4.7) | 17.7 (5.1) | 16.0 (4.1) | 0.0011 | 17.3 (5.3) | 16.6 (4.2) | 0.1742 | 17.5 (4.9) | 16.0 (4.16) | 0.0066 |
| Median [Min, Max] | 16.0 [7.0, 47.0] | 17.0 [8.0, 47.0] | 16.0 [7.0, 44.0] | 16.0 [7.0, 44.0] | 16.0 [7.0, 47.0] | 17.0 [8.0, 47.0] | 16.0 [7.0, 42.0] | ||||
| Cigarettes per day (CPD) | Mean (SD) | 16.3 (8.0) | - | - | - | 13.9 (7.0) | 18.2 (8.3) | <0.0001 | - | - | - |
| Median [Min, Max] | 16.0 [3.0, 45.0] | - | - | 12.5 [3.0, 43.0] | 20.0 [3.0, 45.0] | - | - | ||||
| Nicotine Metabolite Ratio (NMR) | Mean (SD) | 0.53 (1.44) | 0.56 (1.93) | 0.50 (0.48) | 0.7267 | 0.42 (0.30) | 0.62 (1.89) | 0.2159 | 0.54 (1.79) | 0.52 (0.51) | 0.9186 |
| Median [Min, Max] | 0.36 [0.02, 25.1] | 0.34 [0.02, 25.1] | 0.39 [0.08, 4.88] | 0.33 [0.02, 2.18] | 0.39 [0.05, 25.1] | 0.35 [0.02, 25.1] | 0.41 [0.08, 4.88] | ||||
| Log(NMR) | Mean (SD) | −1.00 (0.70) | −1.07 (0.75) | −0.92 (0.64) | 0.0532 | −1.09 (0.68) | −0.93 (0.71) | 0.0399 | −1.08 (0.74) | −1.06 (0.71) | 0.0097 |
| Median [Min, Max] | −1.02 [−3.84, 3.22] | −1.08 [−3.84, 3.22] | −0.95 [−2.53, 1.59] | −1.10 [−3.84, 0.78] | −0.95 [−3.01, 3.22] | −1.06 [−3.84, 3.22] | −0.88 [−2.53, 1.59] | ||||
| Analysis Type | NMR Measure | Smoking Dependence Measures | Effect Size | Results | Association (Y/N) |
|---|---|---|---|---|---|
| Mean Values Low vs. High Dependence | p-Value | ||||
| Bivariate | NMR | FTND Category | 0.56, 0.50 | 0.7267 | N |
| HONC Category | 0.42, 0.62 | 0.2159 | N | ||
| HSI Category | 0.54, 0.52 | 0.9186 | N | ||
| Log(NMR) | FTND Category | −1.07, −0.92 | 0.0532 | N | |
| HONC Category | −1.09, −0.93 | 0.0399 | Y | ||
| HSI Category | −1.08, −1.06 | 0.0097 | Y | ||
| Multi-Variable Models | Bias Corrected Importance | rank(R), p-value | |||
| RF-ML Models | Log(NMR) | FTND | −0.02 | R13, 0.5522 | N |
| HONC | −0.01 | R14, 0.5124 | N | ||
| HSI | 0.00 | R15, 0.4876 | N | ||
| Log(NMR) | FTND Category | 0.03 | R7, 0.1244 | N | |
| HONC Category | 0.01 | R8, 0.3284 | N | ||
| HSI Category | 0.01 | R4, 0.0199 | Y | ||
| Standardized Coefficient Value | rank(R), p-value | ||||
| MLR | NMR, Log(NMR) | FTND | −0.18 | R3, 0.0467 | Y |
| HONC | −0.35 | R2, 0.0157 | Y | ||
| HSI | 0.11 | R8, 0.2891 | N | ||
| BLR | NMR, Log(NMR) | FTND Category | −0.35 | R2, 0.0510 | Y |
| HONC Category | −0.37 | R2, 0.0512 | Y | ||
| HSI Category | 0.15 | R9, 0.4861 | N |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Machiorlatti, M.; Krebs, N.M.; Muscat, J.E. Using Conditional Random Forest and Feature Ranking Algorithms to Determine the Relative Importance of the Nicotine Metabolite Ratio (NMR) and Demographic and Behavioral Factors on Nicotine Dependence Severity. Int. J. Environ. Res. Public Health 2026, 23, 1171. https://doi.org/10.3390/ijerph23091171
Machiorlatti M, Krebs NM, Muscat JE. Using Conditional Random Forest and Feature Ranking Algorithms to Determine the Relative Importance of the Nicotine Metabolite Ratio (NMR) and Demographic and Behavioral Factors on Nicotine Dependence Severity. International Journal of Environmental Research and Public Health. 2026; 23(9):1171. https://doi.org/10.3390/ijerph23091171
Chicago/Turabian StyleMachiorlatti, Michael, Nicolle M. Krebs, and Joshua E. Muscat. 2026. "Using Conditional Random Forest and Feature Ranking Algorithms to Determine the Relative Importance of the Nicotine Metabolite Ratio (NMR) and Demographic and Behavioral Factors on Nicotine Dependence Severity" International Journal of Environmental Research and Public Health 23, no. 9: 1171. https://doi.org/10.3390/ijerph23091171
APA StyleMachiorlatti, M., Krebs, N. M., & Muscat, J. E. (2026). Using Conditional Random Forest and Feature Ranking Algorithms to Determine the Relative Importance of the Nicotine Metabolite Ratio (NMR) and Demographic and Behavioral Factors on Nicotine Dependence Severity. International Journal of Environmental Research and Public Health, 23(9), 1171. https://doi.org/10.3390/ijerph23091171

